Natera
NTRA
#550
Rank
NZ$82.49 B
Marketcap
NZ$568.92
Share price
3.13%
Change (1 day)
54.92%
Change (1 year)

P/E ratio for Natera (NTRA)

P/E ratio as of November 2026 (TTM): -131

According to Natera's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -130.771. At the end of 2022 the company had a P/E ratio of -7.21.

P/E ratio history for Natera from 2015 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-7.21-60%
2021-18.0-48.73%
2020-35.288.93%
2019-18.6197.33%
2018-6.2677.57%
2017-3.53-41.29%
2016-6.01-16.01%
2015-7.15

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Vertex Pharmaceuticals
VRTX
31.8-124.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Prothena
PRTA
-10.6-91.92%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Paratek Pharmaceuticals
PRTK
-2.03-98.45%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.